Global Veterinary Vaccine Market Report By Type, Porcine Vaccines (Poultry Vaccines, Livestock Vaccines (Bovine Vaccines, Small Ruminant Vaccines1), Companion Animal Vaccines (Canine Vaccines, Feline Vaccines), Aquaculture Vaccines, Other Animal Vaccines), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccines), By Route of Administration (Injection Vaccines, Oral Vaccines, Intranasal/Spray Vaccines), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2022-2030

As per this study, the Global Veterinary Vaccine Market was valued USD 9.5 BN (by revenue) in 2022 and is anticipated to reach USD 16.08 BN by 2030 with a CAGR of 6.8%.
 
Vaccine is a biological preparation of inactive or attenuated antigens used to raise immune response in an individual. Veterinary vaccines are the vaccine especially designed for pets or cattle to immune them from particular disease or epidemics. Various vaccines are developed for foot and mouth diseases, flu, rabies, and others to prevent pets from common diseased condition.
 
Market Dynamics
 
Rising livestock population coupled with growing prevalence of zoonotic diseases are the factors driving the market growth. Increasing pet ownership and growing expenditure on pet healthcare is another factor boosting the market growth. In addition to this, ongoing R&D activities to develop more efficient DNA vaccine and attenuated vaccine over a range of disease are likely to spur the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of veterinary vaccine.
 
Market Segmentation
 
The broad veterinary vaccine market has been sub-grouped into, application and animal. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.

By Type

• Porcine Vaccines
• Poultry Vaccines
• Livestock Vaccines (Bovine Vaccines, Small Ruminant Vaccines1)
• Companion Animal Vaccines (Canine Vaccines, Feline Vaccines)
• Aquaculture Vaccines
• Other Animal Vaccines

By Technology

• Live Attenuated Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Other Vaccines

By Route of Administration

• Injection Vaccines
• Oral Vaccines
• Intranasal/Spray Vaccines

By Distribution Channel

• Veterinary Hospitals
• Veterinary Clinics
• Retail Pharmacies

 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for veterinary vaccine in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Global Veterinary Vaccine Market Share by Region (Representative Graph)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the veterinary vaccine market include Zoetis, Inc.(US), Merck & Co, Inc. (US), Boehringer Ingelheim International GmbH (Germany), Elanco Animal Health (US), Virbac (France), Ceva Santé Animale (France), Phibro Animal Health Corporation (US), Hester Biosciences Limited (India), Neogen Corporation (US), HIPRA (Spain), Biogénesis Bagó (Argentina), Tianjin Ringpu Bio-Technology Co. Ltd. (China), China Animal Husbandry Group (China), Jinyu Bio-technology (China), Vaxxinova International BV (Netherlands), Eridovac Animal Health (US), Brilliant Bio Pharma (India), Aptimmune (US), Indian Immunologicals Ltd. (India), Torigen Pharmaceuticals Inc. (US), VEROVACCINES GmbH (Germany), Intas Pharmaceuticals (India), Ourofino Animal Health (Brazil), Biovac (Israel), and Laboratoire LCV (France). An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.